Smoking Pattern and Influencing Factors in Hospitalized Patients

Smoking Behaviors Clinical Trial

Official title:

A Survey of Smoking Patterns and Influencing Factors Among Hospitalized Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05959512
• Other study ID #: Smoking pattern in patients
• Status: Not yet recruiting
• Start date: July 19, 2023
• Est. completion date: December 30, 2024

Study information

• Verified date: July 2023
• Source: Beijing Normal University
• Contact: Xue Weng
• Phone: 3621259
• Email: xueweng[@]bnu.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study examines the smoking patterns and determinants of inpatients who smoke, develops tailored smoking cessation interventions based on their individual needs, and aims to enhance the effectiveness of quitting and lower the likelihood of relapse.

Description:

Smoking is a major risk factor for many chronic and acute diseases, and quitting smoking can bring significant health benefits. However, many smokers find it hard to quit or relapse after quitting. This study aims to explore the smoking behavior and influencing factors of inpatients who smoke. The survey will collect data on the demographic, clinical, psychological, and behavioral aspects of the participants, as well as their smoking history, nicotine dependence, withdrawal symptoms, confidence and motivation to quit, and perceived barriers and facilitators to quitting.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Est. completion date: December 30, 2024
• Est. primary completion date: July 14, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. aged 18 and above;

2. smoke at least 1 cigarette daily;

3. willing to participate in this study

Exclusion Criteria:

1. Smokers who have mental illness or cognitive impairment;

2. Unable to complete the questionnaire survey

Related Conditions & MeSH terms

• Smoking Behaviors

Locations

Country	Name	City	State
China	Xue Weng	Zhuhai	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Beijing Normal University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Smoking cessation rate at 6 months after discharge	The number of participants who quit smoking at 6 months after discharge, verified by carbon monoxide (CO) test	6 months after discharge
Secondary	Smoking reduction rate at 6 months after discharge	The number of participants who reduce their daily cigarette consumption by at least 50% at 6 months after discharge	6 months after discharge
Secondary	Quit attempt rate during the 6-month follow-up period	The number of participants who make at least one quit attempt during the 6-month follow-up period, verified by self-report	6 months after discharge
Secondary	Nicotine dependence level	The level of nicotine dependence, measured by the Fagerström Test for Nicotine Dependence (FTND) at baseline, discharge, and 6 months after discharge	Baseline, and 6 months after discharge